Epstein Secrets

ined guarantee of 3 billion doses, as well as the option for more," in the lead ABC World News Tonight (12/7, lead story, 4:35, Muir, 7.46M) story, Jonathan Karl reported ABC has "confirmed that Pfizer offered to sell the US government additional doses of its COVID-19 vaccine late this summer, but the Trump

y believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek (12/7, 1.53M) that Al-Qaeda "has sidestepped the dilemma of leadership

News Tonight <https://playvideo.bulletinintelligence.corn/5b195fa7ae9443da93d006d5c502a045?pubid=fbi> (12/7, lead story, 4:35, Muir, 7.46M) story, Jonathan Karl reported ABC has "confirmed that Pfizer offered to sell the US government additional doses of its COVID-19 vaccine late this summer, but the Trump A

ey believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek <https://www.newsweek.com/reports-al-qaedas-demise-are-greatly-exagge

ned guarantee of 3 billion doses, as well as the option for more," in the lead ABC World News TonightVi (12/7, lead story, 4:35, Muir, 7.46M) story, Jonathan Karl reported ABC has "confirmed that Pfizer offered to sell the US government additional doses of its C0VID-19 vaccine late this summer, but the Trump

y believe he's at risk of committing further terrorist acts." Opinion: Al-Qaeda Persists Despite Shifting US Priorities, Is Poised For "Comeback." Colin P. Clarke, a Senior Research Fellow at The Soufan Center, writes in an op-ed in Newsweek (12/7, 1.53M) that Al-Qaeda "has sidestepped the dilemma of leadershi